EA007490B1 - N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств - Google Patents

N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств Download PDF

Info

Publication number
EA007490B1
EA007490B1 EA200400893A EA200400893A EA007490B1 EA 007490 B1 EA007490 B1 EA 007490B1 EA 200400893 A EA200400893 A EA 200400893A EA 200400893 A EA200400893 A EA 200400893A EA 007490 B1 EA007490 B1 EA 007490B1
Authority
EA
Eurasian Patent Office
Prior art keywords
oxo
dihydro
methyl
phenyl
oxazolidinecarboxamide
Prior art date
Application number
EA200400893A
Other languages
English (en)
Russian (ru)
Other versions
EA200400893A1 (ru
Inventor
Ричард К. Томас
Тони-Джо Пол
Михаил Р. Барбачин
Михаил Ф. Гордеев
Гэри У. Люр
Адам Ренсло
Апиндер Сингх
Original Assignee
Фармация Энд Апджон Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон Компани filed Critical Фармация Энд Апджон Компани
Publication of EA200400893A1 publication Critical patent/EA200400893A1/ru
Publication of EA007490B1 publication Critical patent/EA007490B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EA200400893A 2002-02-25 2003-02-24 N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств EA007490B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35949502P 2002-02-25 2002-02-25
PCT/US2003/003125 WO2003072553A1 (en) 2002-02-25 2003-02-24 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials

Publications (2)

Publication Number Publication Date
EA200400893A1 EA200400893A1 (ru) 2005-02-24
EA007490B1 true EA007490B1 (ru) 2006-10-27

Family

ID=27766097

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400893A EA007490B1 (ru) 2002-02-25 2003-02-24 N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств

Country Status (36)

Country Link
US (1) US6919329B2 (https=)
EP (1) EP1478629B1 (https=)
JP (1) JP2005524660A (https=)
KR (1) KR100613532B1 (https=)
CN (1) CN1639135A (https=)
AP (1) AP1902A (https=)
AR (1) AR038536A1 (https=)
AT (1) ATE342258T1 (https=)
AU (1) AU2003210807A1 (https=)
BR (1) BR0307924A (https=)
CA (1) CA2476038A1 (https=)
CO (1) CO5611128A2 (https=)
CY (1) CY1105797T1 (https=)
DE (1) DE60308998T2 (https=)
DK (1) DK1478629T3 (https=)
EA (1) EA007490B1 (https=)
EC (1) ECSP045245A (https=)
ES (1) ES2271615T3 (https=)
GE (1) GEP20074198B (https=)
HR (1) HRP20040717A2 (https=)
IS (1) IS7376A (https=)
MA (1) MA27180A1 (https=)
MX (1) MXPA04008205A (https=)
MY (1) MY135233A (https=)
NO (1) NO20044062L (https=)
NZ (1) NZ534521A (https=)
OA (1) OA12779A (https=)
PL (1) PL372461A1 (https=)
PT (1) PT1478629E (https=)
SI (1) SI1478629T1 (https=)
TN (1) TNSN04163A1 (https=)
TW (1) TW200305568A (https=)
UA (1) UA80112C2 (https=)
WO (1) WO2003072553A1 (https=)
YU (1) YU72804A (https=)
ZA (1) ZA200406362B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2522582C2 (ru) * 2008-11-20 2014-07-20 Панацеа Биотек Лтд. Новые противомикробные средства
RU2655928C1 (ru) * 2009-02-03 2018-05-30 Мерк Шарп Энд Домэ Корп. Кристаллические частицы для приготовления твердых лекарственных форм для лечения бактериальных инфекций, реакционная смесь, содержащая такие частицы, и фармацевтическая композиция для лечения бактериальных инфекций

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2004033449A1 (en) * 2002-10-10 2004-04-22 Pharmacia & Upjohn Company Llc Antimicrobial 1-aryl dihydropyridone compounds
BRPI0409217A (pt) * 2003-04-09 2006-03-28 Pharmacia & Upjohn Co Llc derivados e análogos antimicrobianos da [3.1.0]bicicloexilfeniloxazolidinona
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
JP5043428B2 (ja) 2003-06-03 2012-10-10 リブ−エックス ファーマシューティカルズ,インコーポレイテッド ビアリール複素環式化合物ならびにその製造および使用方法
DE602004027811D1 (de) 2003-07-02 2010-08-05 Kyorin Seiyaku Kk Cyclopropylgruppensubstituierte oxazolidinonantibiotika und derivate davon
WO2005005399A1 (en) * 2003-07-02 2005-01-20 Merck & Co., Inc. Oxazolidinone antibiotics and derivatives thereof
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2005082900A2 (en) * 2004-01-28 2005-09-09 Pharmacia & Upjohn Company Llc Oxazolidinone amidoximes as antibacterial agents
MX2007001526A (es) * 2004-08-06 2007-03-27 Pharmacia & Upjohn Co Llc Oxazolidinonas que contienen oxindoles como agentes antibacterianos.
EP1819699A2 (en) * 2004-11-29 2007-08-22 Pharmacia & Upjohn Company LLC Diazepine oxazolidinones as antibacterial agents
EE05394B1 (et) * 2004-12-24 2011-04-15 Janssen Pharmaceutica N.V. Kinoliinihendid kasutamiseks latentse tuberkuloosi ravis
NZ561613A (en) 2005-02-18 2010-12-24 Astrazeneca Ab Antibacterial piperidine derivatives
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
EP1874782A1 (en) 2005-04-15 2008-01-09 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
DE602006019870D1 (de) 2005-06-08 2011-03-10 Rib X Pharmaceuticals Inc Verfahren zur synthese von triazolen
WO2007000644A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
WO2007004037A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidinone carboxamides containing azetidine and cyclobutane as antibacterial agents
WO2007004032A1 (en) * 2005-07-06 2007-01-11 Pharmacia & Upjohn Company Llc Oxazolidiones containing cyclobutane as antibacterial agents
JP2009520785A (ja) * 2005-12-23 2009-05-28 アストラゼネカ アクチボラグ 抗菌性のピロロピリジン、ピロロピリミジン、及びピロロアゼピン
WO2007088478A1 (en) * 2006-02-01 2007-08-09 Pfizer Products Inc. Indazole oxazolidinones as antibacterial agents
KR20080110877A (ko) 2006-03-31 2008-12-19 재단법인 이쯔우 연구소 헤테로환을 갖는 신규 화합물
WO2008026563A1 (en) * 2006-08-30 2008-03-06 Shionogi & Co., Ltd. Hydrazine amide derivative
WO2008026564A1 (en) * 2006-08-30 2008-03-06 Shionogi & Co., Ltd. Urea derivative
US8178683B2 (en) * 2007-08-06 2012-05-15 Micurx Pharmaceuticals, Inc. Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
WO2009044777A1 (ja) 2007-10-02 2009-04-09 Research Foundation Itsuu Laboratory 7員ヘテロ環を有するオキサゾリジノン誘導体
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
BR112012000657A2 (pt) 2009-06-26 2016-11-16 Panacea Biotec Ltd novos azabicilohexanos
WO2012007500A2 (de) 2010-07-15 2012-01-19 Bayer Cropscience Ag Neue heterocyclische verbindungen als schädlingsbekämpfungsmittel
UA112897C2 (uk) 2012-05-09 2016-11-10 Байєр Фарма Акцієнгезелльшафт Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
CN105612166B (zh) 2014-02-21 2019-02-19 上海盟科药业有限公司 治疗用水溶性(o-羰基)氨基磷酸酯前药
JP7205529B2 (ja) * 2018-02-26 2023-01-17 住友化学株式会社 オキサゾリジノン化合物の製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697408A1 (de) * 1994-08-19 1996-02-21 MERCK PATENT GmbH Substituierte 1-phenyl-oxazoliden-2-one Derivate und ihre Verwendung als Adhäsionsrezeptor-Antagonisten
WO2003006440A2 (en) * 2001-07-12 2003-01-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
US5043443A (en) * 1988-07-29 1991-08-27 Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives
US5182403A (en) * 1988-09-15 1993-01-26 The Upjohn Company Substituted 3(5'indazolyl) oxazolidin-2-ones
US5225565A (en) * 1988-09-15 1993-07-06 The Upjohn Company Antibacterial 3-(fused-ring substituted)phenyl-5β-amidomethyloxazolidin-2-ones
US5164510A (en) * 1988-09-15 1992-11-17 The Upjohn Company 5'Indolinyl-5β-amidomethyloxazolidin-2-ones
EP0417044A3 (en) 1989-09-07 1991-06-12 Ciba-Geigy Ag Oxazolidinones and thiones as plantgrowth regulators
US5231188A (en) * 1989-11-17 1993-07-27 The Upjohn Company Tricyclic [6.5.51]-fused oxazolidinone antibacterial agents
ATE146783T1 (de) * 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
KR950702417A (ko) 1992-07-08 1995-07-29 로렌스 티. 웰츠 마이코박테륨 투베르쿨로시스에 대해 유용한 5′-인돌리닐 옥사졸리디논(5′-indolinyl oxazolidinones useful against mycobacterium tuberculosis)
EP0673370B1 (en) * 1992-12-08 1998-01-07 PHARMACIA & UPJOHN COMPANY Tropone-substituted phenyloxazolidinone antibacterial agents
US5688792A (en) * 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
EP0730591B1 (en) * 1993-11-22 1999-07-14 PHARMACIA & UPJOHN COMPANY Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
JPH0873455A (ja) 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
DE4425612A1 (de) * 1994-07-20 1996-04-04 Bayer Ag 6-gliedrige stickstoffhaltige Heteroaryl-oxazolidinone
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
DE19514313A1 (de) * 1994-08-03 1996-02-08 Bayer Ag Benzoxazolyl- und Benzothiazolyloxazolidinone
JP3933198B2 (ja) 1994-10-26 2007-06-20 ファルマシア・アンド・アップジョン・カンパニー フェニルオキサゾリジノン抗菌剤
BR9509673A (pt) * 1994-11-15 1997-09-30 Upjohn Co Compostos e uso dos mesmos
DK0807112T3 (da) 1995-02-03 2001-12-17 Upjohn Co Antimikrobiel heteroaromatisk ringsubstitueret phenyloxazolidinon
HRP960159A2 (en) * 1995-04-21 1997-08-31 Bayer Ag Benzocyclopentane oxazolidinones containing heteroatoms
NZ306310A (en) 1995-05-11 2001-05-25 Upjohn Co Spirocyclic and bicyclic diazinyl and carbazinyl oxazolidinones
RU2175324C2 (ru) * 1995-09-01 2001-10-27 Фармация Энд Апджон Компани Фенилоксазолидиноны, имеющие с-с-связь с 4-8-членными гетероциклическими кольцами
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19601265A1 (de) * 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
DE19601627A1 (de) * 1996-01-18 1997-07-24 Bayer Ag Heteroatomhaltige Cyclopentanopyridyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) * 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
DE69716925T2 (de) * 1996-08-21 2003-09-11 Pharmacia & Upjohn Co., Kalamazoo Isoxazoline derivate und ihre verwendung als antimikroben
CN1138765C (zh) 1997-05-30 2004-02-18 法玛西雅厄普约翰美国公司 带有硫代羰基功能基的噁唑烷酮抗菌剂
DE19730847A1 (de) 1997-07-18 1999-01-28 Bayer Ag Tricyclisch substituierte Oxazolidinone
GB9717804D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
US6083967A (en) 1997-12-05 2000-07-04 Pharmacia & Upjohn Company S-oxide and S,S-dioxide tetrahydrothiopyran phenyloxazolidinones
DE19802235A1 (de) 1998-01-22 1999-07-29 Bayer Ag Mit tricyclischen Indolen substituierte Oxazolidinone
DE19802239A1 (de) 1998-01-22 1999-07-29 Bayer Ag Neue mit Bicyclen substituierte Oxazolidinone
KR20010015910A (ko) * 1998-01-23 2001-02-26 로렌스 티. 마이젠헬더 옥사졸리디논 조합 라이브러리, 조성물 및 제조 방법
DE19805117A1 (de) 1998-02-09 1999-08-12 Bayer Ag Neue Oxazolidinone mit azolhaltigen Tricyclen
TR200003595T2 (tr) 1998-06-05 2001-07-23 Astrazeneca Ab Kimyasal bileşikler
GB9821938D0 (en) 1998-10-09 1998-12-02 Zeneca Ltd Chemical compounds
EP1149089B1 (en) * 1999-02-01 2003-03-26 PHARMACIA & UPJOHN COMPANY PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
ES2203473T3 (es) 1999-05-27 2004-04-16 PHARMACIA & UPJOHN COMPANY Oxazolidinonas biciclicas como agentes antibacterianos.
GB9928499D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical processes and intermediates
HUP0203869A2 (hu) 1999-12-21 2003-07-28 Pharmacia & Upjohn Co. Szulfoximin funkcionalitással rendelkező oxazolidinok és alkalmazásuk mikrobaellenes szerként, a vegyületeket tartalmazó gyógyszerkészítmények
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0100110D0 (en) 2001-01-04 2001-02-14 Univ Leeds Modulation of calcium channel activity
GB0113297D0 (en) 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697408A1 (de) * 1994-08-19 1996-02-21 MERCK PATENT GmbH Substituierte 1-phenyl-oxazoliden-2-one Derivate und ihre Verwendung als Adhäsionsrezeptor-Antagonisten
WO2003006440A2 (en) * 2001-07-12 2003-01-23 Pharmacia & Upjohn Company Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BRICKNER S. J.: "Oxazolidinone antibacterial agents", CURRENT PHARMACEUTICAL DESIGN, vol. 2, no. 2, 1996, pages 175-194, XP001007528, the whole document *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2522582C2 (ru) * 2008-11-20 2014-07-20 Панацеа Биотек Лтд. Новые противомикробные средства
RU2655928C1 (ru) * 2009-02-03 2018-05-30 Мерк Шарп Энд Домэ Корп. Кристаллические частицы для приготовления твердых лекарственных форм для лечения бактериальных инфекций, реакционная смесь, содержащая такие частицы, и фармацевтическая композиция для лечения бактериальных инфекций

Also Published As

Publication number Publication date
DK1478629T3 (da) 2007-01-29
EP1478629A1 (en) 2004-11-24
DE60308998T2 (de) 2007-03-01
IS7376A (is) 2004-07-29
AR038536A1 (es) 2005-01-19
EA200400893A1 (ru) 2005-02-24
YU72804A (sh) 2006-08-17
AP1902A (en) 2008-10-15
WO2003072553A8 (en) 2004-09-16
SI1478629T1 (sl) 2007-02-28
MY135233A (en) 2008-03-31
ES2271615T3 (es) 2007-04-16
KR100613532B1 (ko) 2006-08-16
PT1478629E (pt) 2007-01-31
US6919329B2 (en) 2005-07-19
KR20040091668A (ko) 2004-10-28
US20040044052A1 (en) 2004-03-04
ECSP045245A (es) 2004-09-28
TW200305568A (en) 2003-11-01
GEP20074198B (en) 2007-09-25
MXPA04008205A (es) 2004-11-26
AP2004003110A0 (en) 2004-09-30
AU2003210807A1 (en) 2003-09-09
CA2476038A1 (en) 2003-09-04
ZA200406362B (en) 2006-02-22
MA27180A1 (fr) 2005-01-03
UA80112C2 (en) 2007-08-27
JP2005524660A (ja) 2005-08-18
BR0307924A (pt) 2004-12-07
CO5611128A2 (es) 2006-02-28
OA12779A (en) 2006-07-06
PL372461A1 (en) 2005-07-25
EP1478629B1 (en) 2006-10-11
HRP20040717A2 (en) 2005-02-28
WO2003072553A1 (en) 2003-09-04
NO20044062L (no) 2004-10-26
NZ534521A (en) 2007-02-23
TNSN04163A1 (fr) 2007-03-12
DE60308998D1 (de) 2006-11-23
CY1105797T1 (el) 2011-02-02
CN1639135A (zh) 2005-07-13
ATE342258T1 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
EA007490B1 (ru) N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств
JP5199121B2 (ja) Cetp阻害剤
US6313307B1 (en) Phenyloxazolidinones having a C-C bond to 4-8 membered heterocyclic rings
JP3698724B2 (ja) 置換−ヒドロキシアセチルピペラジンフェニルオキサゾリジノンのエステル
US20090318431A1 (en) Benzoxazinone and benzoxazepinone oxazolidinones as antibacterial agents
US20080090884A1 (en) Antimicrobial [3.1.0] bicyclohexylphenyl- oxazolidinone derivatives and analogues
JP3887396B2 (ja) 抗バクテリア・インドロン・オキサゾリジノン、その製造用中間体、及びそれを含有する医薬組成物
US20040014967A1 (en) Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound
US7645781B2 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20160297771A1 (en) Substituted uracils and use thereof
US20040127530A1 (en) Antimibicrobial [3.1.0.] bicyclic oxazolidinone derivatives
US7105547B2 (en) Antimicrobial 1-aryl dihydropyridone compounds
WO2005082897A1 (en) Oxazolidinone antibacterial agents
US6825225B2 (en) Bicyclic isoxazolinones as antibacterial agents
US20040142939A1 (en) N-Aryl-2-oxazolidinone-5-carboxamides and their derivatives
US20040204463A1 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU